Publications by authors named "Pierre Palmer"

Claim this Profile
S
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.
Isaline Coquet, Juliette Pavie, Pierre Palmer, François Barbier, Stéphane Legriel

Crit Care· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV.
Anne Rachline, Pierre Palmer, François Simon, Jean-Michel Molina

J Med Virol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.
Constance Delaugerre, Blandine Denis, Gilles Peytavin, Pierre Palmer, Thomas Mourez

J Clin Microbiol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?
Dominique Costagliola, Florence Damond, Pierre Palmer, Christine Rouzioux, Françoise Brun-Vezinet

AIDS· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern and impact of emerging resistance mutations in treatment experienced patients failing darunavir-containing regimen.
Constance Delaugerre, Juliette Pavie, Pierre Palmer, Jade Ghosn, Stephane Blanche

AIDS· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial).
Jean-Michel Molina, Valérie Journot, André Furco, Pierre Palmer, Nathalie De Castro

Antivir Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.
Pierre Palmer, Michael G Tovey, Franck Raschilas, Lilia Brassart, Jean-François Meritet

Eur Cytokine Netw· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
Geneviève Chêne, Bahia Amellal, Gaëlle Pédrono, Karine Gourlain, Corinne Rancinan, Pierre Palmer

AIDS Res Hum Retroviruses· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases.
Anne Bourgarit, Caroline Lascoux, Pierre Palmer, Ewa Tuleja, Claire Pintado

AIDS· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].
Juliette Pavie, Raphäl Porcher, Sandra Fournier, Furco André, Caroline Tournoux, Pierre Palmer

Presse Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Anne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, Philippe Colson, Emmanuel Guillevic, Pierre Palmer

Antimicrob Agents Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
Diane Descamps, Marie-Laure Chaix, Patrice André, Véronique Brodard, Jacqueline Cottalorda, Pierre Palmer

J Acquir Immune Defic Syndr· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.
Jean-Michel Molina, Valérie Journot, Laurence Morand-Joubert, Patrick Yéni, Willy Rozenbaum, Pierre Palmer

J Infect Dis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients.
Bernard Masquelier, Catherine Tamalet, Brigitte Montès, Diane Descamps, Gilles Peytavin, Pierre Palmer

Antivir Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis